T. Rowe Price reports 4.3% stake in argenx SE ADRs
T. Rowe Price Associates, Inc. reports beneficial ownership of 2,675,457 ADRs of argenx SE as of June 30, 2026, representing 4.3% of the ADR class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
T. Rowe Price Associates, Inc. reports beneficial ownership of 2,675,457 ADRs of argenx SE as of June 30, 2026, representing 4.3% of the ADR class. The firm has sole voting power over 2,649,465 ADRs and sole dispositive power over 2,675,457 ADRs, with no shared voting or dispositive power.
The position is reported as ownership of 5 percent or less of the class. T. Rowe Price Associates, Inc. states that this report should not be construed as an admission of beneficial ownership and that such beneficial ownership is expressly denied.
Key Figures
Key Terms
beneficially owned financial
sole voting power financial
sole dispositive power financial
Ownership of 5 percent or less of a class financial
CUSIP financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in ARGX does T. Rowe Price Associates report in this Schedule 13G/A?
How much voting power in ARGX ADRs does T. Rowe Price Associates have?
What dispositive power over ARGX ADRs is reported by T. Rowe Price Associates?
Does T. Rowe Price Associates claim beneficial ownership of ARGX securities?
Is T. Rowe Price Associates a 5% or greater holder of ARGX ADRs?
AI-generated analysis. How Rhea-AI works. Not financial advice.